7,275,170 Shares in Philip Morris International Inc. $PM Purchased by Legal & General Group Plc

Key Points

• Legal & General Group purchased 7.28 million Philip Morris shares worth approximately $1.32 billion, giving it a 0.47% stake; institutional investors collectively own 78.63% of the company.
• Philip Morris reported strong quarterly results, with revenue rising 10.4% year over year to $11.19 billion and EPS of $2.20 surpassing the $2.05 consensus estimate. The company guided for third-quarter EPS of $2.20–$2.25.
• The FDA authorized 11 ZYN ULTRA nicotine pouch products, supporting Philip Morris’s smoke-free growth strategy. Analysts maintain a broadly positive view, with a “Moderate Buy” consensus and an average price target of $205.89.

Legal & General Group Plc purchased a new stake in Philip Morris International Inc. (NYSE:PM - Free Report) in the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor purchased 7,275,170 shares of the company's stock, valued at approximately $1,316,151,000. Legal & General Group Plc owned about 0.47% of Philip Morris International at the end of the most recent quarter.

Several other hedge funds also recently made changes to their positions in the business. AG Campbell Advisory LLC acquired a new stake in Philip Morris International during the fourth quarter valued at approximately $25,000. Portfolio Resources Advisor Group Inc. bought a new position in shares of Philip Morris International in the fourth quarter valued at $26,000. Vermillion Wealth Management Inc. lifted its position in shares of Philip Morris International by 146.5% during the 1st quarter. Vermillion Wealth Management Inc. now owns 175 shares of the company's stock valued at $29,000 after acquiring an additional 104 shares during the last quarter. Caitong International Asset Management Co. Ltd acquired a new stake in shares of Philip Morris International during the 2nd quarter valued at $29,000. Finally, Safe Harbor Fiduciary LLC bought a new stake in shares of Philip Morris International during the 4th quarter worth $29,000. Institutional investors and hedge funds own 78.63% of the company's stock.

Philip Morris International Stock Performance

NYSE PM opened at $191.48 on Tuesday. The firm's 50 day moving average price is $186.22 and its two-hundred day moving average price is $178.46. Philip Morris International Inc. has a twelve month low of $142.11 and a twelve month high of $207.76. The stock has a market cap of $298.44 billion, a price-to-earnings ratio of 27.51, a PEG ratio of 2.27 and a beta of 0.38.

Philip Morris International (NYSE:PM - Get Free Report) last released its earnings results on Wednesday, July 22nd. The company reported $2.20 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.05 by $0.15. The company had revenue of $11.19 billion during the quarter, compared to analyst estimates of $10.60 billion. Philip Morris International had a negative return on equity of 163.41% and a net margin of 11.06%.The company's revenue for the quarter was up 10.4% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.89 earnings per share. Philip Morris International has set its Q3 2026 guidance at 2.200-2.25 EPS. On average, research analysts forecast that Philip Morris International Inc. will post 8.33 EPS for the current fiscal year.

Philip Morris International Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Monday, July 20th. Investors of record on Thursday, June 25th were paid a $1.47 dividend. This represents a $5.88 annualized dividend and a yield of 3.1%. The ex-dividend date of this dividend was Thursday, June 25th. Philip Morris International's dividend payout ratio is currently 84.48%.

Philip Morris International News Summary

Here are the key news stories impacting Philip Morris International this week:

• Positive Sentiment: The FDA granted Marketing Granted Orders for 11 ZYN ULTRA nicotine pouch products in the United States, including all 9mg variants and one 11mg variant. The authorization broadens PM’s smoke-free portfolio, supports regulatory certainty for ZYN, and reinforces the company’s long-term shift away from combustible tobacco. Philip Morris' ZYN ULTRA FDA Authorization Strengthens Smoke-Free Push
• Positive Sentiment: Recent second-quarter results provided additional support for the stock: revenue increased 10.4% year over year to $11.19 billion, while adjusted earnings of $2.20 per share exceeded the $2.05 consensus estimate. The company also issued third-quarter earnings guidance of $2.20 to $2.25 per share. Should Strong Q2 Results And New FDA-Authorized ZYN ULTRA Pouches Require Action From Philip Morris Investors?
• Neutral Sentiment: PM and Altria Group NYSE: MO entered reciprocal contract manufacturing agreements intended to improve manufacturing efficiency and operational flexibility. PM’s non-U.S. affiliates will manufacture certain combustible cigarettes for Philip Morris USA, while the arrangements also provide reciprocal production capabilities. First shipments are expected in 2027, and the companies said the agreements should not materially affect 2026 results, limiting the near-term earnings impact. Altria, Philip Morris International sign contract manufacturing deals

Wall Street Analyst Weigh In

PM has been the topic of a number of recent research reports. BTIG Research set a $221.00 target price on Philip Morris International and gave the stock a "buy" rating in a report on Friday, July 24th. Morgan Stanley upped their target price on Philip Morris International from $200.00 to $215.00 and gave the company an "overweight" rating in a report on Thursday, July 23rd. Bank of America reiterated a "buy" rating on shares of Philip Morris International in a research report on Thursday, May 21st. Citigroup lifted their price target on Philip Morris International from $210.00 to $225.00 and gave the stock a "buy" rating in a research note on Thursday, July 30th. Finally, Stifel Nicolaus boosted their price objective on Philip Morris International from $195.00 to $205.00 and gave the stock a "buy" rating in a report on Thursday, July 23rd. Ten research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $205.89.

Philip Morris International Company Profile

Philip Morris International Inc NYSE: PM is a global tobacco company that manufactures and sells cigarettes, other nicotine-containing products and a growing portfolio of smoke-free alternatives for adult smokers. The firm traces its corporate roots to the 19th century Philip Morris enterprise and was established as an independent, publicly traded company following a 2008 separation from what is now Altria. Since the spin-off, the company has focused on serving international markets outside the United States.

PMI's product mix includes traditional combustible cigarettes as well as smoke-free offerings such as heated tobacco systems and other reduced-risk products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source